Fouad Namouni Net Worth & Insider Trades

Fouad Namouni - PRESIDENT, Blueprint Medicines Corp

As of March 8, 2022

What is Fouad Namouni's Net Worth?

The current estimated net worth of Blueprint Medicines Corp's PRESIDENT, Fouad Namouni, is estimated to be about $2.34M . Fouad Namouni owns about 56,274 units of Blueprint Medicines Corp common stock. In the last 2 years at Blueprint Medicines Corp, Fouad Namouni has sold an estimated value of $377.03K worth.

What is Fouad Namouni's Past Insider Trading?

Fouad Namouni's largest sale order was 3,241 units , worth over $318.2K on October 7, 2021. In total, Fouad Namouni has made about 5 transactions over 2 years of their time at Blueprint Medicines Corp. Fouad Namouni usually trades in March, with the busiest year in 2021 and 2022. The most recent transaction was a sale order of 1,047 units , worth over $58.83K on March 8, 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Fouad Namouni's Salary in 2020?

As PRESIDENT of Blueprint Medicines Corp, Fouad Namouni has a total base salary of $186,154 . Fouad Namouni received compensation valued at about $6,668,732 in 2020 after becoming PRESIDENT.

What is Fouad Namouni's' Mailing Address?

  • Mailing address is 535 Boylston St., 2nd Floor Boston MA 02116 MA

Blueprint Medicines Corp Executive Compensation

Name
Year
Salary
Total
Jeffrey W. Albers 2020 $645,000 $6,344,667
Jeffrey W. Albers 2019 $590,000 $9,362,371
Jeffrey W. Albers 2018 $541,144 $9,740,799
Michael Landsittel 2020 $379,575 $2,014,974
Michael Landsittel 2019 $345,000 $1,958,720
Michael Landsittel 2018 $281,678 $1,740,610
Fouad Namouni, M.D. 2020 $186,154 $6,668,732
Fouad Namouni, M.D. 2019 - -
Fouad Namouni, M.D. 2018 - -
Kathryn Haviland 2020 $460,944 $2,363,556
Kathryn Haviland 2019 $431,830 $3,090,423
Kathryn Haviland 2018 $392,589 $2,601,762
Tracey L. McCain, Esq. 2020 $453,301 $2,346,428
Tracey L. McCain, Esq. 2019 $437,972 $2,900,568
Tracey L. McCain, Esq. 2018 $425,216 $2,647,962
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1597264/000155837021004557/tmb-20210602xdef14a.htm

What are Blueprint Medicines Corp's Past Insider Trades?

Blueprint Medicines Corp's most recent insider trade came on August 26, 2022 by Debra Dursobumpus who sold 5,000 units worth $375.55K . In the last 7 years, insiders at Blueprint Medicines Corp have sold an estimated value of $172.49M and bought an estimated value of $17.41M worth of shares. Insider trading is most common in March, with the busiest year in 2020. The most active traders at the company are Jeffrey Albers,  Ariel Hurley, PRINCIPAL ACCOUNTING OFFICER,  and Kate Haviland, CHIEF OPERATING OFFICER .

Blueprint Medicines Corp Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1